Diebold Nixdorf (DBD) Cash & Equivalents (2009 - 2026)

Diebold Nixdorf's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $373.6 million for Q1 2026.

• Quarterly Cash & Equivalents rose 16.68% year-over-year to $373.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $373.6 million (up 16.68% YoY) and the FY2025 annual result came in at $387.3 million, up 24.41% from the prior year.
• Cash & Equivalents was $373.6 million for Q1 2026 at Diebold Nixdorf, down from $387.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $592.3 million in Q4 2023 and bottomed at $128.4 million in Q3 2022.
• A 5-year average of $315.1 million and a median of $281.9 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 192.91% — and 2024, when it sank 47.44%.
• Diebold Nixdorf's Cash & Equivalents stood at $319.1 million in 2022, then soared by 85.62% to $592.3 million in 2023, then sank by 47.44% to $311.3 million in 2024, then grew by 24.41% to $387.3 million in 2025, then fell by 3.54% to $373.6 million in 2026.
• Business Quant data shows DBD's Cash & Equivalents at $373.6 million in Q1 2026, $387.3 million in Q4 2025, and $246.1 million in Q3 2025.